Nippon Shokubai (TSE:4114) Rallies On Mixed Valuation Signals, Is The Stock A Bargain?

Nippon Shokubai (TSE:4114) has drawn renewed attention after its recent share performance, with the stock down about 1% over the past month but up roughly 23% in the past 3 months.

The recent 22.6% 90-day share price return and 27.2% year-to-date share price gain suggest momentum in Nippon Shokubai is building, while the 46.4% one-year and 115.6% three-year total shareholder returns point to a much stronger longer-term payoff profile.

Scan how Nippon Shokubai fits within its sector by comparing it to a hand-picked list of solid balance sheet and fundamentals (21 results) that have shown resilience through a range of market conditions.

Nippon Shokubai now trades at a discount to one estimate of fair value, yet sits above the average analyst target. That split view sets up a simple test: Is the market’s caution grounded in something investors should respect?

Preferred P/E of 16.8x: Is it justified?

Nippon Shokubai looks cheap on the SWS DCF model, which points to a fair value of approximately ¥3,569.94 against a last close of ¥2,577.5, but the market is still paying a richer P/E of 16.8x than several benchmarks.

The P/E ratio compares the share price with earnings per share and, for a chemicals producer like Nippon Shokubai, it is a quick way to see how much investors pay for each unit of current profit. A higher P/E usually signals that the market is building in stronger profitability or a high level of confidence in the earnings stream.

Here the valuation is not low fitted against peers. Nippon Shokubai trades on a P/E of 16.8x compared with an estimated fair P/E of 13.8x and a JP Chemicals industry average of 12.9x. It also sits above the peer group average of 14.8x, which is a clear premium. That gap sets a high bar for future performance if the multiple were to move closer to the fair ratio level.

Explore the SWS fair ratio for Nippon Shokubai.

Result: Price-to-earnings of 16.8x (OVERVALUED).

Still, the premium P/E leaves Nippon Shokubai exposed if earnings momentum stalls or if sentiment toward the broader Japanese chemicals sector cools quickly.

Find out about the key risks to this Nippon Shokubai narrative.

Another view on Nippon Shokubai’s value

The SWS DCF model pulls in the opposite direction to that premium P/E. On this framework, Nippon Shokubai screens as undervalued, with an estimated fair value of about ¥3,569.94 against the current price of ¥2,577.5. If one lens says expensive and another says cheap, which one do you trust more?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Nippon Shokubai for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 17 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If the mixed signals around Nippon Shokubai leave you on the fence, use that tension as a prompt to act now. Test the numbers for yourself, then weigh the company’s 3 key rewards and 1 important warning sign through the 3 key rewards and 1 important warning sign

Looking for more ideas beyond Nippon Shokubai?

Once you have a view on Nippon Shokubai, you can keep your momentum going. Fresh ideas may help you stay flexible, identify potential mispricing more quickly, and reduce concentration risk.

• Explore potential mispricing by scanning a curated set of companies flagged as 17 high quality undervalued stocks relative to their fundamentals.
• Review a focused group of 14 dividend fortresses that offer substantial yields supported by their financial profiles.
• Consider dialing down portfolio stress by checking a hand picked 21 resilient stocks with low risk scores built around resilient balance sheets and lower risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com